Bazedoxifene/conjugated estrogens

Bazedoxifene/conjugated estrogens
Combination of
Bazedoxifene	Selective estrogen receptor modulator
Conjugated estrogens	Estrogen
Clinical data
Trade names	Duavee, Duavive
AHFS/Drugs.com	Professional Drug Facts
MedlinePlus	a614004
License data	US DailyMed: Duavee;
Pregnancy; category	AU: D;
Routes of; administration	By mouth
ATC code	G03CC07 (WHO) ;
Legal status
Legal status	CA: ℞-only; US: ℞-only; EU: Rx-only; In general: ℞ (Prescription only);
Identifiers
CAS Number	1422348-02-4;
ChemSpider	None;
KEGG	D10579;

Bazedoxifene/conjugated estrogens, sold under the brand name Duavee among others, is a fixed-dose combination medication for the treatment of menopause symptoms and postmenopausal osteoporosis.^[3]^[5]^[6] It contains the selective estrogen receptor modulator bazedoxifene and conjugated estrogens.^[3] It is taken by mouth.^[3]

Quick Facts Combination of, Conjugated estrogens ...

The combination was approved for medical use in the United States in October 2013,^[7] and in the European Union in December 2014.^[4]

See also